- Home
- CMS vs PODD Comparison
CMS vs PODD Comparison
Compare CMS & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMS
- PODD
- Stock Information
- Founded
- CMS 1987
- PODD 2000
- Country
- CMS United States
- PODD United States
- Employees
- CMS N/A
- PODD N/A
- Industry
- CMS Power Generation
- PODD Medical/Dental Instruments
- Sector
- CMS Utilities
- PODD Health Care
- Exchange
- CMS Nasdaq
- PODD Nasdaq
- Market Cap
- CMS 21.0B
- PODD 21.5B
- IPO Year
- CMS N/A
- PODD 2007
- Fundamental
- Price
- CMS $68.73
- PODD $313.40
- Analyst Decision
- CMS Buy
- PODD Strong Buy
- Analyst Count
- CMS 11
- PODD 19
- Target Price
- CMS $76.73
- PODD $320.11
- AVG Volume (30 Days)
- CMS 2.6M
- PODD 824.3K
- Earning Date
- CMS 07-24-2025
- PODD 08-07-2025
- Dividend Yield
- CMS 3.14%
- PODD N/A
- EPS Growth
- CMS 3.06
- PODD 67.46
- EPS
- CMS 3.38
- PODD 5.55
- Revenue
- CMS $7,786,000,000.00
- PODD $2,198,900,000.00
- Revenue This Year
- CMS $7.25
- PODD $24.49
- Revenue Next Year
- CMS $4.13
- PODD $17.45
- P/E Ratio
- CMS $20.47
- PODD $56.50
- Revenue Growth
- CMS 5.87
- PODD 23.48
- 52 Week Low
- CMS $58.50
- PODD $173.00
- 52 Week High
- CMS $76.45
- PODD $329.33
- Technical
- Relative Strength Index (RSI)
- CMS 42.41
- PODD 57.19
- Support Level
- CMS $68.41
- PODD $299.47
- Resistance Level
- CMS $69.61
- PODD $315.49
- Average True Range (ATR)
- CMS 0.82
- PODD 7.30
- MACD
- CMS -0.02
- PODD -0.76
- Stochastic Oscillator
- CMS 12.21
- PODD 87.91
About CMS CMS Energy Corporation
CMS Energy is an energy holding company with three principal businesses. Its regulated utility, Consumers Energy, provides regulated natural gas service to 1.8 million customers and electric service to 1.9 million customers in Michigan. NorthStar Clean Energy, formerly CMS Enterprises, is engaged in wholesale power generation, including contracted renewable energy. CMS sold EnerBank in October 2021.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.